SCHEMBL26047491

SCHEMBL26047491

COCOc1cc(OC)cc(C)c1CCC(=O)OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE3B Q13370 1/20 0.42
▸ PDE3A Q14432 1/20 0.42
▸ TSHR P16473 1/20 0.37
▸ BACE1 P56817 2/20 0.37
▸ CYP3A4 P08684 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ GAA P10253 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ HTT P42858 2/20 0.35
▸ CAPN1 P07384 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21957646 0.92 PDE3B (0.43) PDE3BPDE3ATSHRBACE1CYP3A4
SCHEMBL28413351 0.79 POLB (0.44) CYP3A4HPGDKDM4EHSD17B10ALDH1A1
SCHEMBL12586318 0.74 CYP3A4 (0.58) TSHRBACE1CYP3A4HPGDGAA
SCHEMBL4102407 0.73 KMT2A (0.49) TSHRBACE1CYP3A4HPGDGAA
SCHEMBL21957647 0.71 NFKB1 (0.47) PDE3BPDE3ATSHRBACE1CYP3A4
SCHEMBL6934496 0.71 CYP3A4 (0.38) BACE1CYP3A4HPGDGAAKDM4E
SCHEMBL26951403 0.71 PDE3B (0.45) PDE3BPDE3ATSHRCYP3A4HPGD
SCHEMBL5882994 0.70 PDE3B (0.45) PDE3BPDE3ABACE1GAAKDM4E
SCHEMBL5990756 0.70 HSP90AB1 (0.47) PDE3BPDE3ATSHRCYP3A4HPGD
SCHEMBL5882542 0.69 PDE3B (0.44) PDE3BPDE3ABACE1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11690810-B2 Combination treatment of bacterial infection THE CHINESE UNIVERSITY OF HONG KONG (CN) 2023-07-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11690810-B2 Combination treatment of bacterial infection PGC, NRDC, PYCARD PDE3B 1380/4885PDE3A 1296/4885TSHR 4521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback